Stock 4263 SUSMED,INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings SUSMED,Inc.

Equities

4263

JP3319150003

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-01 am EDT 		5-day change 1st Jan Change
547 JPY +0.37% Intraday chart for SUSMED,Inc. +2.05% -59.03%
2023 SUSMED,Inc.(TSE:4263) added to S&P Global BMI Index CI
2022 Walgreens Boots Alliance, Inc. Joins Sustainable Medicines Partnership CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • Based on current prices, the company has particularly high valuation levels.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

Ratings chart - Surperformance

Sector: IT Services & Consulting

1st Jan change Capi. Investor Rating ESG Refinitiv
SUSMED,INC. Stock SUSMED,Inc.
-59.03% 57.9M -
ACCENTURE PLC Stock Accenture plc
-14.53% 189B
A-
TATA CONSULTANCY SERVICES LTD. Stock Tata Consultancy Services Ltd.
+0.72% 166B
B+
IBM Stock IBM
+1.28% 152B
B-
AUTOMATIC DATA PROCESSING, INC. Stock Automatic Data Processing, Inc.
+8.68% 99.37B
A-
RELX PLC Stock RELX PLC
+6.11% 77.36B
A-
CROWDSTRIKE HOLDINGS, INC. Stock CrowdStrike Holdings, Inc.
+14.46% 70.76B
C-
INFOSYS LIMITED Stock Infosys Limited
-7.93% 70.46B
A
SNOWFLAKE INC. Stock Snowflake Inc.
-21.65% 51.83B
C
HCL TECHNOLOGIES LIMITED Stock HCL Technologies Limited
-6.79% 44.34B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 4263 Stock
  4. Ratings SUSMED,Inc.